Categories
Pharmaceutical

Von Hippel-Lindau Market Look a Witness of Excellent Long-Term Growth – Worldwide Survey by 2031

Fact.MR has prepared a research study on Global Von Hippel-Lindau Market and has made use of a multi-disciplinary approach to come up with a detailed and clear picture of the evolution of the Global Von Hippel-Lindau Market for the forecast period. This study offers an in-depth analysis of the key prospects of growth, main growth avenues in the estimation year and existing growth dynamics over the assessment period. At the same time, the report also prepares the stakeholders for effectively dealing with the threats and challenges in the global Von Hippel-Lindau Market.

The researchers and analysts and authoring this report have taken into consideration several factors estimated to exert both negative and positively influence the global Von Hippel-Lindau Market. The authors of the report have carefully analyzed the current pandemic situation and its effect on the industry. The report also assesses how Covid-19 has changed the way business is done and how it is going to change the dynamics of the market in the years to come. Analysts at Fact.MR has carefully analyzed the market in the pre- and present Covid-19 era to arrive at projections and estimations for the Global Von Hippel-Lindau Market in the post-pandemic era.

To Remain ‘Ahead’ Of Your Competitors, Request For A Sample https://www.factmr.com/connectus/sample?flag=S&rep_id=5289

Von Hippel-Lindau Market: Drivers and restraints
The tumors can occur in ten different parts of the body which includes kidney, brain, pancreas, eyes, spine, inner ears, adrenal glands, liver, lung and reproductive tract. The Von Hippel-Lindau disease is different in every patient, even within the same family. Therefore it is very difficult to predict how and when the Von Hippel-Lindau disease will present in the individual. There is no drug available till date to cure the Von Hippel-Lindau disease. However the surgical removal is the only method to treat the Von Hippel-Lindau disease. Besides, early detection, careful monitoring and appropriate treatment can reduce the prevention of Von Hippel-Lindau disease.

Segmentations:
The Von Hippel-Lindau market can be segmented by tumor site, diagnosis, and end user.
Based on tumor site the Von Hippel-Lindau market can be segmented as

  • Brain
  • Spine
  • Eyes
  • Kidneys
  • Adrenal Glands
  • Pancreas
  • Liver
  • Lungs
  • Inner Ears
  • Reproductive Tract

Based on diagnosis the Von Hippel-Lindau market can be segmented as

  • MRI Scan
  • CT Scan
  • Others

Based on the end user the Von Hippel-Lindau market can be segmented as

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

To receive extensive list of important regions, ask for TOC here : https://www.factmr.com/connectus/sample?flag=T&rep_id=5289

Von Hippel-Lindau Market: Key market players

Some of the major players operating in the Von Hippel-Lindau market are Eli Lilly and Company, Bedford Laboratories, DNAtrix, Inc., Astellas US Holding, Inc., Advantagene, Inc, Burzynski Research Institute, Inc., Cellectar Biosciences, Inc. and Direct Therapeutics, Inc. among others.

Von Hippel-Lindau Market: Region wise outlook
North America is expected to share high market value in Von Hippel-Lindau market owing to its growing research activities, increasing awareness of early diagnosis, and high research and development investments followed by Europe. Considerable market growth of Von Hippel-Lindau has also been expected from the Asia Pacific countries due to the increasing incidences of tumor and Von Hippel-Lindau disease.

Some important questions that the Von Hippel-Lindau Market report tries to answer exhaustively are:

  • Who could be the target audience, particularly in the chemicals and materials industry, for the global Von Hippel-Lindau Market?
  • How the report would assist the market players in making effective strategies?
  • Which of the applications of the said product or service could influence the contours of the global Von Hippel-Lindau Market in the near future?
  • How Covid-19 could cause disruptions in the supply chain of the chemical and materials industry?
  • What factors of the market are likely to hold lucrativeness for the market players?
  • What could restrain the expansion of the market in the chemicals and materials industry?
  • Which of the product or service segment could prove to be most lucrative for the market?
  • What are the recent market developments that could influence the global Von Hippel-Lindau Market?
  • How technological advancements are likely to impact the market in the near future?
  • What macro and micro factors are at play in each of the regions of the market?
  • How competition in the market is likely to influence the decisions of the market players?
  • What are COVID-19 implications on the global Von Hippel-Lindau Market and learn how businesses can respond, manage, and mitigate the risks?

Read More Trending Reports of Fact.MR – https://www.biospace.com/article/palmoplantar-pustulosis-manufacturers-to-rely-on-novel-drugs-discovery-for-expansion-in-future-fact-mr/

Read More Trending Reports of Fact : https://www.biospace.com/article/is-pcr-market-moving-toward-personalized-medicine-new-study-explores/

Explore Fact.MR’s Coverage on the Healthcare Domain:
Anti-Snoring Treatment Market According to the latest research by Fact.MR., the anti-snoring treatment market is set to witness steady growth during 2021-2031.

Artificial Retina Market According to the latest research by Fact.MR., the artificial retina market is observed steady growth during 2021-2031.

Brain Implant Market According to latest research by Fact.MR., brain implants market is observer stead growth during 2021-2031.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Colored Contact Lenses Market Expecting the Unexpected future in 2031; SWOT analysis, investment feasibility analysis

Fact.MR, a global research & consulting firm, in their updated edition of the report, states that the colored contact lenses market is projected to record a robust growing pace in 2021 & beyond. The expansion can be primarily attributed to growing number of eye disorder cases as well as increasing number of users needing to correct their eye anomalies. Major companies are providing multiple colored contact lenses (blue, hazel, violet, grey, green, amethyst, and brown) which pulls in more consumers to buy their product. Expansion in the eyewear industry is further poised to generate new prospects in the market.

A detailed study by Fact.MR on the demand for Colored Contact Lenses market provides an in-depth evaluation of various growth drivers, trends, and opportunities, the prevailing regulatory landscape in various regions, and the competitive scenario amidst the COVID-19 pandemic.

To Remain ‘Ahead’ Of Your Competitors, Request For A Sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=1139

Growing adoption of cosmetic lenses together with rising fashion trends are majorly fuelling the industry expansion. Accessibility of stylish cosmetic lenses in local markets with diverse attractive textures, colors, and shades to improve eyes appearance is functioning as a favourable aspect for the coloured contact lenses market.

Furthermore, higher penetration of social media together with higher investment in social media optimization and search engine optimization by leading market players are projected to encourage the industry growth in the forthcoming years.

Colored Contact Lenses Market: Segmentation
Tentatively, the global colored contact censes market can be segmented on the basis of type, distribution channel, and geography.

Based on type, the global colored contact censes market is segmented as:

  • Visibility Tint
  • Enhancement Tint
  • Opaque Tint
    • Hazel
    • Green
    • Blue
    • Violet
    • Amethyst
    • Brown
    • Gray
    • Custom

Based on Distribution Channel, the global colored contact lenses market is segmented as:

  • Optical Stores
  • Retail Pharmacies
  • Drugstores
  • E-commerce

Share Your Requirements & Get Customized Reports https://www.factmr.com/connectus/sample?flag=RC&rep_id=1139

For More Detailed Information about SWOT Analysis of Top Players:-

Examples of some of the major players in the global colored contact lenses market are Cooper Companies Johnson & Johnson, Novartis, Valeant, Carl Zeiss, Essilor, HOYA GROUP, UltraVision CLPL and Wesley Jessen. Technological advancement in already marketed products is the major trend emerging in the global colored contact lenses market.

How Insights and Analysis by Fact.MR Make Difference?

The in-depth assessment of various growth dynamics of the Colored Contact Lenses market and insights on market estimations help all market participants to stay ahead in the curve of growth with a worldwide economic impact of COVID-19. Some of the insights that can make the difference are:

  • Most rapidly expanding region and the top revenue-generating region.
  • Trends that are outliers to the historical growth of various regional markets.
  • Products, services, and technologies that will attract sizable research and investment funding by governments of different countries
  • Macroeconomic dynamics that may make a characteristic change in the growth trajectory of the overall Colored Contact Lenses market.

Browse More Reports by Fact.MR : https://www.biospace.com/article/introduction-of-novel-drugs-and-treatment-methods-to-help-uptake-of-basal-cell-carcinoma-treatment-market-finds-fact-mr/  

Explore Fact.MR’s Healthcare Reports
Artificial Eye Lenses Market: Delve into Fact.MR’s extensive study on the artificial eye lenses market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.

Artificial Eyes Market: The global artificial eyes market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.

Eye socket Implants Market: Fact.MR’s global eye socket implants market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Global Psychotic Disorder Treatment Market Is Anticipated To Register a Significant CAGR over A Forecast Period

Fact.MR, a global research firm, in its latest study on the global psychotic disorder treatment market is projected to record a notable CAGR in 2021 & beyond. The growth is projected to be fuelled by increasing cases of mental disturbances, such as stress, trauma, and depression. Additionally, increasing inventions of the molecules and growing medical and healthcare investment in the research & development of metal disorders are favouring expansion of psychotic disorder treatment industry.

The demand for psychotic disorder drugs and equipment’s witnessed a slowdown globally in 2020 due to stringent regulations imposed in Covid-19 pandemic. World Health Organisation on 10 October, 2020 declared that Covid-19 halted critical mental health services by 93%through a survey of 130 countries while the need for mental health is increasing. As the condition is getting stabilized in 2021, the market players are focusing on recovering their position through continuous researches, innovations and developments.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=568

Psychotic Disorder Treatment Market: Drivers and Restraints

The global psychotic disorder treatment market is anticipated to register a significant CAGR over a forecast period. The increasing research and development activities for the new drugs and new combinations of drugs to minimize the adverse effects of the antipsychotics drugs and increase safety and efficacy of the drug is anticipated to boost the demand for the psychotic disorder drugs and drives the global psychotic disorder treatment market. Increasing the number of prevalence of severe psychotic disorder is likely to fuel the growth of global psychotic disorder treatment market. The rising in the awareness among people is also anticipated to drives the global psychotic disorder treatment market.

However, the possible side effects of the antipsychotics drugs may hamper the demand for the psychotic disorder treatment and restrain the growth of the global psychotic disorder treatment market. Lack of specific drugs and methods is a significant challenge to ensure the treatment is another factor that hinder the demand for the psychotic disorder treatment and restrain the growth of global psychotic disorder treatment market.

Psychotic Disorder Treatment Market: Segmentation

The global Psychotic disorder treatment market is segmented on the basis of drug type, indication and distribution channel:

On the basis of drug type, the global psychotic disorder treatment market is segmented into:

  • Atypical antipsychotics
  • Phenothiazine antipsychotics
  • Thioxanthenes
  • Miscellaneous antipsychotics agents

On the basis of indication, the global psychotic disorder treatment market is segmented into:

  • Schizophrenia
  • Bipolar disorder
  • Delusional disorder
  • Drug induced psychosis
  • Organic psychosis

To receive extensive list of important regions, ask for TOC here – https://www.factmr.com/connectus/sample?flag=T&rep_id=568

On the basis of distribution channel, the global psychotic disorder treatment market is segmented into:

  • Hospital pharmacies
  • Retail pharmacies
  • Drug store
  • E-commerce

Psychotic Disorder Treatment Market: Key Players

Some of the major market players in psychotic disorder treatment market globally includes: Teva Pharmaceutical Industries Ltd, Sanofi S.A., Allergan, Plc, Pfizer Inc, Novartis International AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., Amgen Inc., F. Hoffmann-La Roche Ltd, Mylan N.V. and others. These companies are highly focused on the development of advanced Psychotic disorder treatment devices further contributing to the growth of psychotic disorder treatment globally.

The US will continue to Reflect Lucrative Growth Prospects

The US is contributing majority of shares to the in value terms owing to rise in the number of occurrence of severe psychotic disorder amid people and will record a notable CAGR in 2021 & beyond.

China & India are also contributing moderate shares and will reflect a robust growth pace for psychotic disorder treatment.

The UK is projected to be the most lucrative region. On the other hand, UAE, Turkey, Kenya along with other regions is still at a nascent stage and is anticipated to record a decent expansion in the forthcoming years.

Read More Trending Reports of Fact.MR : https://www.globenewswire.com/en/news-release/2020/03/05/1995769/0/en/Premium-Brands-Pushing-Whiskey-Market-Prospects-through-2029-Blended-Grain-Whiskeys-to-Remain-Top-Selling-Projects-a-New-Fact-MR-Study.html

Explore Fact.MR’s Healthcare Reports

Pulsed Field Gel Electrophoresis (PFGE) Systems Market: Delve into Fact.MR’s extensive study on the Pulsed Field Gel Electrophoresis (PFGE) market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.

Subcutaneous Injection Ports Market: The global subcutaneous injection ports market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.

Penile Prostheses Market: Fact.MR’s global penile prostheses market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Global Cardiac Mapping System Market to Offer Increased Growth Prospects for Manufacturers

According to Fact MR’s recent market research, Cardiac Mapping System sales will increase at propelled CAGR by 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Fact.MR, a global research & consulting firm, in their updated edition of the report, states that the cardiac mapping system market will foresee a robust growth pace in 2021 & beyond. The growth is mainly driven by growing geriatric population trailed by growing incidences and prevalence of heart disorders.

Request a report sample to gain valuable insights at : https://www.factmr.com/connectus/sample?flag=S&rep_id=1131

The advent of cardiac mapping systems enabled electrophysiologists to target and treat complex arrhythmias more effectively than ever. According to the Centers for Disease Control and Prevention, more than 600,000 people die of heart disease in the United States, every year, making it essential for the medical professionals to take strong awareness initiatives to tell people about the availability of cardiac mapping technology, in a move to control the ever-growing cardiac deaths.

A cardiac mapping system, such as a 3D cardiac mapping system, can do wonders in preventing deaths caused by heart disease, but the lack of awareness about cardiac medical devices continue to increase the cardiac related hospitalizations. The awareness of 3D cardiac mapping system can give rise to the adoption of the systems, which eliminate errors in diagnosis, thereby helping the physicians in delivering better treatment and cure.

Over years the technology in healthcare industry has changed significantly, paving the way for many high-tech cardiac mapping systems. Newer cardiac mapping systems have revolutionized the clinical electrophysiology laboratory in recent time by offering novel insights into arrhythmia mechanisms. Based on novel approaches, these systems can accurately determine the three-dimensional location of the mapping catheter, however, their price tag continue to hamper adoption in hospitals, especially in private clinics.

Manufacturers of cardiac mapping systems have been incorporating rapidly advancing technology to optimize the safety and efficacy of catheters. The cardiac mapping system market players are likely to witness novel growth opportunities, on the back of growing demand for technologically-advanced cardiac mapping systems, because as the population ages, cardiac arrhythmias cases are expected to increase

Cardiac Mapping System Market: Segmentation
On the basis of technology, cardiac mapping system market can be segmented as:

  • Cardiac radionuclide imaging
  • Remote Navigation Systems
  • Magnetic Navigation System
  • Robotic Navigation Systems

On the basis of the end user, the cardiac mapping system market can be segmented as:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnosis Centers

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1131

Cardiac Mapping System Market: Region-wise Outlook
In terms of geography, cardiac mapping system market has been divided into eight regions including North- America, Eastern Europe, Western Europe, and Asia- Pacific excluding China & Japan (APECJ), China, Japan, Middle-East & Africa and Latin America. North America is the most dominating market for cardiac mapping system market due to increasing healthcare expenditure and adoption of new technologies in cardiac mapping such as 3D mapping. Western Europe like Germany, France, and the UK is another fastest growing region in cardiac mapping system market due to growing healthcare practices and development of manufacturing facilities. APECJ region includes two fastest developing countries India and China, which provide the most promising market for cardiac mapping system market players. Due to factors like increasing awareness, rapid improvement in healthcare services, large population pool and increased prevalence of cardiac diseases.

Cardiac Mapping System Market: Key Market Participants
Example of some key market participants in global cardiac mapping system market identify across the value chain are Biosense Webster Inc. (Johnson & Johnson), Boston Scientific Corporation, Medical Computer Systems Ltd., Abbott Laboratories, Aurora Health Care, Medtronic plc, General Electric Company and other.

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, ASEAN, Australia & New Zealand)
  • China
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Read More Trending Reports of Fact.MR: https://www.biospace.com/article/demand-for-acute-surgical-mechanical-circulatory-support-system-propelled-by-growing-prevalence-of-hf-says-fact-mr/

Explore Fact.MR’s Coverage on the Healthcare Domain
Bone Growth Stimulator Market: A recent study by Fact.MR on the bone growth stimulator market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth.

Bone Marrow Processing System Market: Fact.MR gives a detailed assessment of bone marrow processing system market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

Injectable Bone Graft Substitutes Market: Fact.MR delivers an in-depth analysis on global injectable bone graft substitutes market with the strategies and competitive landscape through 2021 and beyond. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Over 1/5th of the Global Antidiabetic Medicine Market Shall be Held by Asia-Pacific : Report Fact.MR

The World Health Organization (WHO) predicts that the global geriatric population (65 and above) constitute the maximum share of world population. By 2050, the number of elderly people shall reach 2 billion, a 22% increase since the beginning of the 21st century. Naturally, there is an uptick in the prevalence of chronic ailments among people. This has also stimulated the growth of the geriatric healthcare industry.

Based on the abovementioned trends, the global demand for geriatric medicines is anticipated to expand positively at a CAGR of 6.0% during the forecast period (2020-2026). Increased government support for elderly healthcare and technological advancements in medical assistance are other important drivers behind the growth of the geriatric medicines market.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4746

Global Geriatric Medicines Market Segmentation

Fact.MR has studied the global geriatric medicines market with detailed segmentation on the basis of therapeutic category, condition, distribution channel, and region.

Therapeutic Category

  • Analgesic
  • Anti-hypertensive
  • Statins
  • Anti-diabetic
  • Proton Pump Inhibitor
  • Anti-coagulant
  • Anti-psychotic and Anti-depressant

Condition

  • Cardiovascular
  • Arthritis
  • Diabetes
  • Neurological
  • Cancer
  • Osteoporosis
  • Respiratory
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4746

global geriatric  medicines  market 01

Key Takeaways of Global Geriatric Medicines Market Study:

  • By therapeutics, analgesic drugs are projected to dominate the global geriatric medicines market, growing at a CAGR of 6.0% and capturing greater than two-fifth market share. Usage of painkillers such as Ibuprofen and Diclofenac to address chronic conditions such as arthritis are anticipated to drive the segment’s growth.
  • The antihypertensive segment is anticipated to catch up, registering a CAGR of 6.5%. Increased prevalence of hypertension owing to changing lifestyles is a key growth determinant for this segment.
  • By condition, the cardiovascular segment shall retain market hegemony over the forecast period. Projections indicate a market share exceeding two-fifths of the global geriatric medicines market. Increasing incidences of cardiac arrests and strokes among the geriatric population is anticipated to boost market prospects.
  • By distribution channel, hospitals are anticipated to account for the maximum market share, capturing more than half of the global geriatric medicines market. Expanding base of hospitals and surge in the number of hospital visits for treatment of various chronic diseases are poised to steer growth.
  • North America shall retain market leadership throughout the forecast period. The region is anticipated to expand at a CAGR of 5.9%, capturing nearly 2/5th of the global geriatric medicines market. Rising cases of diseases such as obesity, presence of key market players, emerging clinical studies and research projects are anticipated to boost the region’s growth.
  • Asia-Pacific shows lucrative growth prospects. Rising prevalence of diseases due to a large population base and investment in health infrastructure shall also drive the region’s growth. Asia-Pacific is poised to expand at a CAGR of 6.7%, capturing 1/5th of the global geriatric medicines market.
  • The coronavirus pandemic is set to leverage the geriatric medicines market. As the number of infections rise daily, the most vulnerable pool is the geriatric population. This is because they already suffer from chronic conditions, thus rendering them immunocompromised.
  • Key players are ensuring that their supply chains in the geriatric medicines segment is not compromised. Moreover, they are also investing in clinical trials to develop critical drug formulations which could help eradicate the coronavirus.
  • Astra Zeneca, for instance, has initiated a clinical trial to assess whether one of their drugs has the potential to alleviate the exaggerated immune response posed by the coronavirus infection. The trial would help assess how one of their existing medicines would help alleviate the cytokine storm associated with the coronavirus disease.

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4746

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –http://www.globenewswire.com/en/news-release/2018/08/08/1549081/0/en/Orthopedic-Implants-Market-Sales-in-Knee-Reconstruction-Pre-eminent-Hip-Reconstruction-to-Gain-Steady-Momentum-slates-Fact-MR.html

Product Development for Pipeline Drugs and Collaborations to be Key Growth Catalysts

The global geriatric medicines market comprises of the following prominent market players: AstraZeneca, Merck & Co, Inc., Pfizer, Inc., Novartis AG, Bristol-Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Abbott Laboratories and Boehringer Ingelheim GmbH. Most of these companies concentrate on establishing a strong market presence through launch of new products, acquisitions & agreements and partnerships with local businesses.

For instance, Pfizer Inc., collaborated with Basilea Pharmaceutica Ltd. for marketing CRESEMBA, an anti-fungal medicine used to treat aspergillosis and mucormycosis in the Asia-Pacific in 2017. Presently, the company manufactures a wide range of products ranging from internal medicines, vaccines, oncology and rare diseases. Some of its medications are Zithromax, Zyvox, Zavicefta, Cresemba, Vfend and Tygacil.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Glucose Monitoring Devices will Grow at a Healthy 3.5% Value CAGR By 2026

Fact.MR, in its latest market study, opines that the Sales of home diagnostics will grow at a healthy 3.5% value CAGR, surpassing US$ 6.3 million by 2026.

Companies in the Home Diagnostics Market are facing issues in keeping their production facilities fully functional due to shortage of staff and resources amidst the COVID-19 (Coronavirus) outbreak. Get a hands-on over key drivers and threats to the Home Diagnostics Market to make your company future-ready post the pandemic. Avails out reports for exciting prices to learn new opportunities that companies can capitalize on during and after the Coronavirus crisis.

For detailed insights on enhancing your product footprint, request a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1892

Fact.MR, in its latest market study, opines that the home diagnostics market will grow at a healthy 3.5% value CAGR, surpassing US$ 6.3 million by 2026. According to the report, sales will remain buoyant in developed regions, with North America and Europe collectively accounting for over 50% revenue share of the market. The Fact.MR study remains bullish on the prospects of home diagnostics market players in developing countries, as growing focus on health & wellness, and emergence of many Asian countries as medical tourism hubs creates opportunities.

Increasing preference for self-diagnosis continues to be a trigger for home diagnostics sales, whereas a combination of industry-specific and regulatory factors continue to influence the strategies of market players. Governing bodies such as the U.S. Food and Drug Administration (FDA) and the European Commission regulate home diagnostics with stringent quality control regulations and labeling requirements.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=1892

Market Segmentation:

By Test Type

  • Glucose Monitoring Devices
  • Pregnancy Test
  • HIV Test Kits
  • Ovulation Predictor Test Kits
  • Cholesterol Detection Test Kits
  • Drug of Abuse Test Kits

By Form

  • Cassettes
  • Strips
  • Midstream
  • Digital Monitoring
  • Instruments
  • Test
  • Dip Cards

By Regional Market and Country-wise Segmentation

  • North America
  • USA
  • Latin America
  • Europe
  • France
  • Asia Pacific
  • Middle East
  • Africa
  • China

By Distribution Channel

  • Retail Pharmacies
  • Drug Stores
  • Hypermarkets / Supermarkets
  • Online Pharmacies

For instance, Abbott Laboratories, a leading pharmaceutical company in the U.S., recently got an FDA approval for marketing its FreeStyle® Libre 14 day Flash Glucose Monitoring system in the U.S. ACON Laboratories, another prominent player in the home diagnostics market announced that it has received FDA clearance of Mission® U120 urine reagent strips. According to the report, compliance to ever-evolving regulations and gaining regulatory approval remains both an opportunity and challenge for market players.

home diagnostics market 1

The Fact.MR study finds that glucose monitoring devices will continue to witness robust demand and dominate the home diagnostics market with over than 80% revenue share in the market. According to the World Health Organization (WHO), the number of people suffering from diabetes reached 422 million in 2014, and it will soon become a leading cause of death. Increasing prevalence of diabetes worldwide and the growing need for monitoring sugar levels among diabetes patients is likely to boost adoption of glucose monitoring devices during the assessment period. Home diagnostics market players are aware of the surging demand for glucose monitoring devices, and are focusing on increasing their product portfolio in this segment. The other lucrative segments in the home diagnostics market include pregnancy tests and ovulation prediction kits.

For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=1892

According to the report, although demand for home diagnostics is concentrated in developed countries, home diagnostics market players are putting efforts to boost uptake in developing regions. According to statistics published by WHO, the prevalence of diabetes has been the highest in middle and low-income countries.

Anticipating the burgeoning demand for glucose monitoring devices in emerging Asia, players in the home diagnostics market are shifting their focus towards developing nations, including China and India. ARKRAY, Inc. – a Japanese manufacturer in the home diagnostics market – recently announced that it will strengthen its diabetes testing instrument production capacity in China. Leading manufacturers in the home diagnostics market are modifying their marketing strategies to improve awareness about cost-effective and efficient home diagnostics to leverage lucrative opportunities in the Asia-Pacific region.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/09/11/1914197/0/en/Peak-Flow-Meters-to-Ride-on-Portability-Quotient-Gains-Remain-Driven-by-Introduction-of-Smart-and-Efficient-Variants-Fact-MR.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

North America Dominates the Broth Dilution Method of Antimicrobial Susceptibility Test Market By 2025

Fact.MR, the antimicrobial susceptibility test market is projected to record year-over-year growth of 6.5% in 2020, over 2019.

Opportunities for players in the antimicrobial susceptibility test market are likely to arise from increasing public-private partnerships in the healthcare sector. These partnerships are intended to encourage the free flow of finance for the development of effective products. Despite this financial lucidity, the high development cost of testing kits, given the complexity and tedious nature of testing, could adversely impact returns on investment of manufacturers.

Diagnostic laboratories and hospitals are projected to remain crucial end users, and a substantial chunk of product sales will close from the clinical diagnosis of bacteria, fungi, and parasites.

Click HERE To get a SAMPLE PDF (Including Full TOC, Table & Figures) at
https://www.factmr.com/connectus/sample?flag=S&rep_id=4334

Key Highlights of Antimicrobial Susceptibility Test Market Study

  • Ease of sample processing through the use of advanced lab instruments and better turnaround time of samples are projected to create a large patient pool for diagnosis, which, in turn, will amplify the demand for antimicrobial susceptibility test kits during the forecast period.
  • Online sales channels are emerging as an integral revenue stream for the antimicrobial susceptibility test market. These channels are being leveraged by key vendors to disseminate brand information and gain access to local markets.
  • Initiatives taken by central health authorities are projected to draw consumers’ attention towards the importance of antibiotics. For instance, WHO observes a week in November as World Antibiotic Awareness Week (WAAW), to inspire the best clinical practices among health workers and policymakers in order to control antibiotic resistance.
  • Introduction of advanced antimicrobial susceptibility tests, which offer results in around 2 hours, sets the standards for better patient outcomes. For instance, FASTinov announced the launch of a rapid antimicrobial susceptibility test, which is based on flow cytometry, to offer clinically-implementable results in as little as two hours. Such advancements are likely to inspire the development of effective test products.

Antimicrobial Susceptibility Test Market – Assessment of Key Segments

Authors of the report have segmented the antimicrobial susceptibility test market into key categories in order to study the market at a microscopic level. The key segments considered while bifurcating the antimicrobial susceptibility test market include:

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4334

A senior market research analyst at Fact.MR opines that– “An entry into the antimicrobial susceptibility test market is highly capital-intensive, as CAPEX includes the cost of sophisticated equipment and skilled labor. In addition, capital becomes an essential fuel to foster R&D activities, which could create an entry barrier for new players in the antimicrobial susceptibility test market.”

Product Method Test Type Application End User Region
Kits, Reagents, & Consumables Broth Dilution Method Antibacterial Clinical Diagnosis Diagnostic Laboratories and Hospitals North America
Automated Test Systems Rapid Automated Method Antiparasitic Drug Discovery and Development Research and Academic Institutes Latin America
Culture Media Disk Diffusion Method Antifungal Others Pharmaceutical and Biotechnology Companies Europe
Gradient Diffusion Method Others Contract Research Organizations Asia Pacific
Molecular Testing Method Middle East & Africa

Besides laying focus on the aforementioned key segments, the report also studies the antimicrobial susceptibility test market at a country level, to recalibrate the underlying opportunities available for players in the antimicrobial susceptibility test market for the forecast period. Among all the estimated data, the report also includes Y-o-Y growth projections, which can help market players in comprehending the precise trajectory at which the antimicrobial susceptibility test market has been growing.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4334

Key companies profiled in the report on antimicrobial susceptibility test market include bioMérieux SA, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Alifax Holding S.p.A., Creative Diagnostics, Becton, Dickinson and Company, HiMedia Laboratories, Cepheid, Biotron Healthcare, and Conda.

Antimicrobial Susceptibility Test Market – Research Methodology

The antimicrobial susceptibility test market has been evaluated by taking a top-down and bottom-up approach. Demand, geographical presence, distribution strategies by manufacturers, and initiatives taken by governments and NGOs are various factors considered while estimating the revenue of the antimicrobial susceptibility test market for each device, and thus, reaching global numbers. The study on the antimicrobial susceptibility test market is further validated through extensive primary research on the data extracted from exhaustive secondary research.

In order to conduct secondary research, annual company reports, company websites, data from the World Health Organization (WHO), SEC filings, press releases, investor presentations, and other similar resources were studied. To validate the information compiled through secondary research, interviews with key opinion leaders and subject matter experts were scheduled. In addition to this, authors of the report also had email and telephonic interactions with the senior management of leading and prominent companies to confirm the size, growth trends, and future outlook of the antimicrobial susceptibility test market.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

High Demand for 0.2T Systems to Reflect the Growing Need for Low-field Intraoperative MRI Equipment

Traditional image-guided procedures remained restricted to the limitation of physicians referring to pre- and post-operative images for conducting neurosurgical or maxillofacial procedures. With advancements in medical imaging technologies, intraoperative MRI techniques paved their way in the diagnosis-guided surgery landscape, enabling physicians and surgeons to view the images during surgery, rather than referring to them preoperatively or postoperatively. Advanced intraoperative MRI equipment are being developed to facilitate enhanced imaging for physicians and lower the risks of improper surgeries during preoperative conditions.

Fact.MR observes as robust growth in demand for intraoperative MRI equipment in the global healthcare marketplace. By the end of 2026, the global intraoperative MRI equipment market is estimated to surpass US$ 315 million valuation. The advantage of intraoperative MRI equipment in improving the localization for physicians during surgeries will continue to bolster their demand in the near future. During the period, 2017-2026, the global market for intraoperative MRI equipment is assessed to reflect a CAGR of 7.1% in terms of volume.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=519

The Uptake for Intraoperative MRI Equipment to Remain High in Medical Communities

As the years progress, advancements in medical imaging technologies are being welcomed by communities of physicians and surgeons across the globe. Currently, the adoption of intraoperative MRI equipment showcases a promising growth. Leading medical research organizations are exhibiting readiness to invest in technologies for instrumenting developments in the operability and functioning of intraoperative MRI equipment. Multiple advantages of using intraoperative MRI equipment will be driving their uptake in the coming years.

  • Real-time visualization offered by latest intraoperative MRI equipment to improve the efficiency of surgical interventions
  • Gradient-imaging advantage of intraoperative MRI equipment to support physicians in planning the path of surgery
  • Cost-effective maintenance to compensate for high prices of intraoperative MRI equipment
  • The co-efficiency of intraoperative MRI equipment in lowering the chances of second surgical intervention to aid patient outcomes of hospitals

Global Intraoperative MRI Equipment Market: Segmentation

Product Type
  • 0.2T System
  • 1.5T System
  • 3.0T System
  • Others
End User
  • Hospitals
  • Cancer Research Institutes
  • Academic Institutes
  • Other End Users
Application
  • Neurosurgical Intervention
  • Orthopedic Procedures
  • Cardiovascular Intervention
  • Other Applications

Following Questions Answers Covered in the Report are:

  • How will the global Intraoperative MRI Equipment Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Intraoperative MRI Equipment Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Intraoperative MRI Equipment Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=519

global intraoperative mri equipment market

Prominent Players

  • GE Healthcare
  • Medtronic Plc
  • Siemens AG
  • IMRIS Inc.
  • Koninklijke Philips N.V.
  • Hitachi Corporation

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights – https://www.biospace.com/article/osteoporosis-testing-market-growth-spurred-by-surging-cases-of-osteoporosis-says-fact-mr

Neurosurgical Interventions to Represent Highly-Profitable Applications of Intraoperative MRI Equipment

Considering the significance of obtaining quality outcomes during neurosurgeries, advanced equipment are being used across hospitals in the world. Intraoperative MRI equipment are an addition to the range of devices used during neurosurgical intervention. By the end of 2026, more than 1,640 units of intraoperative MRI equipment will be adopted for neurosurgical intervention applications around the world. The report also estimates that orthopedic procedures will represent a fast-growing application of intraoperative MRI equipment during the forecast period.

North America – Largest Market for Intraoperative MRI Equipment through 2026

The report estimates that majority of intraoperative MRI equipment are produced and sold in the US. High value growth in North America’s medical tourism sector will drive the sales of intraoperative MRI equipment in the US and Canada. Companies such as Medtronic Plc, GE Healthcare, IMRIS, Inc., Siemens AG, Hitachi Corporation, and Koninklijke Philips N.V., which are the key players in global intraoperative MRI equipment market are prominent in the US and have gained their footholds across Europe and the Asia-Pacific excluding Japan (APEJ) region.

In the coming years, a steady demand for 0.2T systems will be observed in the global intraoperative MRI equipment landscape. Growing need for low-field MRI in surgical interventions will drive the demand for 0.2T systems across the globe. The report also estimates that 3.0T systems will register a rapid growth in terms of volume, reflecting a 9% CAGR over the forecast period. Manufacturers will continue to extend the production of these two key systems to capture the specific demands of physicians. Moreover, lowering the risks of these systems in creating geometrical distortion will be prioritized by intraoperative MRI equipment manufacturers in the foreseeable future.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=519

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Neonatal Brain Monitoring Equipment Gain High Traction In the Near Future: Fact.MR

Recent Fact.MR report envisages the demand for neonatal monitoring equipment to record a steady 5.7% CAGR during the forecast period (2018-2028). Over 1,070,000 neonatal monitoring equipment are pegged to be sold worldwide by 2028-end.

Increased interest of neonatal monitoring equipment manufacturers in providing technologically-integrated and high-end solutions mirrors the healthcare sector’s inclination toward value-based care. Innovative technology offerings of new neonatal monitoring equipment manufacturers coupled with their attractive pricing has compelled major companies in expanding their product portfolio for meeting the requirement of neonatal intensive care units (NICUs).

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=746

key segments:Neonatal Monitoring Equipment Market

The report has branched the neonatal monitoring equipment market in terms of product type, modality, end-user, and region.

Based on product type, key segments include,

  • Ventilator
  • Pulse Oximeter
  • Capnography Meter
  • Cardiorespiratory Monitor
  • Bilirubinometer
  • EEG Monitor
  • Blood Pressure Monitor

Based on modality, key segments include,

  • Portable Devices
  • Transportable Devices
  • Standalone Devices

Based on end-user, key segments include,

  • Hospitals
  • Neonatal Clinics
  • Nursing Homes
  • Diagnostic Centers
  • Other End-Users

neonatal monitoring equipment market

Following Questions Answers Covered in the Report are:

  • How will the global Neonatal Monitoring Equipment Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Neonatal Monitoring Equipment Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Neonatal Monitoring Equipment Market?
  • How will these strategies influence the market growth and competition?

Full Access of this Report Is Available At https://www.factmr.com/checkout/746

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights – https://www.biospace.com/article/investments-to-improve-cancer-treatments-and-therapeutics-is-helping-development-of-peritoneal-cancer-treatment-market/

Neonatal Monitoring Equipment Market: North America Continues to Stay at Vanguard with High Focus on Palliative Care

North America continues to stay at the vanguard of the neonatal monitoring equipment market, with an estimated market value share of over one-third through the period of forecast. Rate of premature birth has been steadily rising in North America over the past couple of years, according to the CDC, which in turn has increased the number of NICU admissions, thereby creating demand for neonatal monitoring equipment.

Speciality of hospice and palliative medicine has gained significant recognition in North America, with attendant increase in training programs at both academic and clinical level. The imperative role of palliative care in improving growth development outcomes in newborn babies has been highly recognized in the region’s NICUs for reducing the infant and neonatal mortality rates.

Neonatal Monitoring Equipment Market: Ventilators Continue to Hold Bulk Value Shares

Ventilators are set to prevail as preferred product among end-users of neonatal monitoring equipment, and will continues to account for bulk value shares of the market. Recent FDA approvals of new, patient-triggered ventilators, and neurally-adjusted ventilator assist (NAVA), for non-invasive and invasive ventilation related to neonates will augur well for sales of ventilators in the forthcoming years. Additionally, availability of several ventilation modes and strategies for assisting ventilation optimization, and preventing ventilation-induced lung injury will fuel ventilator sales.

Standalone modality of neonatal monitoring equipment will continue to spearhead the market in terms of value share. This is mainly because standalone devices enable clinicians in offering care delivery even while the hospital’s electronic medical records are in their downtime. However, relatively faster sales expansion has been foreseen for portable neonatal monitoring equipment through 2028.

Manufacturers are offering cost-effective portable neonatal monitoring equipment that enable uninterrupted monitoring at the bedside and during in-hospital transport. Growing development of easy-to-use, compact and light portable devices will further fuel their sales in the upcoming years.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=746

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Spine Devices Market is projected to reach US$ 8,348.2 Million revenue by the end of 2022

Low back pain is becoming a very common health problem across the globe. Affecting people of all ages from children to elderly, low back pain can be acute or chronic. The prevalence of spine disease is also on a rise due to increasing aging population, changing lifestyle, constant stress, acute or repetitive injuries and various other conditions. There has been a drastic change in spine surgery, with the robotic spine surgery currently being offered by few healthcare providers, giving patients improved outcome than the traditional surgical procedure.

Manufacturers are also focusing on developing minimally invasive devices. As the less invasive procedure can result in lower pain score and lead to quick recovery time. Surgeons around the world are also focusing on endoscopic techniques leading to less invasive spine care, hence, new technologies are being developed to simplify technically complex procedures. Spine device market manufacturers are also working towards offering better spinal imaging technology for sharper images. Effective in chronic pain conditions, spinal cord stimulation therapy is on a rise, hence, manufacturers are developing spinal cord stimulator devices that can reduce the risk of thermal tissue damage and are compatible with MRI.

Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=259

Hospitals to Witness Maximum Revenue Share

Hospitals are expected to form as strong customer base in the spine devices market as compared to orthopedic clinics. Towards the end of 2017, hospitals are anticipated to account for over two-third revenue share of spine devices market. Hospitals as end users are projected to reach close to US$ 5,700 million by the end of 2022. Increasing number of spinal surgeries performed at hospitals is one of the factors driving expansion of spine devices market.

global spine devices market

Companies are also working on stem cell technology and its use in the spine. According to the latest report by Fact.MR, the global spine devices market is expected to witness massive growth, registering 7.1% CAGR during the forecast period, 2017 to 2022. Owing to an aging population, occupational posture, obesity, etc., spinal diseases are growing rapidly. Hence, spine surgery has also undergone a significant change, with new spine devices being developed to decompress and stabilize the spine. Following insights show how the global spine devices market will perform in the next five years.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=259

Key Insights on Global Spine Devices Market

1. North America is projected to remain dominant in the global spine devices market throughout the forecast period from 2017 to 2022. The market is anticipated to witness the robust growth, reaching close to US$ 2,900 million revenues by the end of 2022. Owing to the availability of healthcare infrastructure and increase in investment by the government to improve healthcare across the region, North America is expected to emerge as the biggest market for spine devices.

2. Asia Pacific Excluding Japan (APEJ) spine devices market is expected to experience impressive growth through 2022. The rise in a number of accidents resulting in spine injury, improving lifestyle and an aging population are some of the factors boosting the growth of APEJ spine devices market.

3. Spinal plates will emerge as one of the most-preferred spine devices. Towards the end of 2017, Spinal plates are projected to gain nearly one-fourth of the revenue share. Meanwhile, spinal screws will also witness healthy growth, reaching nearly US$ 1,500 million revenue by 2022 end.

4. Compared to orthopedic clinics as the end user of spine devices, hospitals will emerge as the biggest users of spine devices. Towards the end of 2022, Hospitals as the end user are projected to surpass US$ 5,600 million revenue. Hospitals are also expected to account for more than two-third revenue share on global revenues by the end of 2017.

Get More Insights-https://www.prnewswire.com/news-releases/us-3-billion-opportunity-emerging-in-spine-devices-market-fact-mr-study-894181246.html

The report has also profiled leading players in the global market for spine devices, which will remain active through 2022. These include companies such as NuVasive, Inc., Exactech, Inc., DePuy Synthes, Braun Melsungen AG., Amedica Corporation, Arthrocare, K2M Group Holding, Inc., Medtronic Plc., Zimmer Biomet Holdings, Inc., and Stryker Corporation.

Explore Fact.MR’s Coverage on the Healthcare Domain

Radiation proctitis treatment market: A recent study by Fact.MR on the radiation proctitis treatment market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Radiation Nephropathy Treatment and Management Market: Fact. MR’s extensive coverage on the radiation nephropathy treatment and management market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Cancer therapeutics market: The global cancer therapeutics market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Research Insight: https://www.factmr.com/report/259/spine-devices-market
Press Release: https://www.factmr.com/media-release/248/spine-devices-market

Follow Us: LinkedIn | Twitter